Controlled release formulation of divalproic acid and its derivatives

Details for Australian Patent Application No. 2006335344 (hide)

International Classifications

Event Publications

12 March 2009 Section 223 Application Received

Not Given An application to extend the time from 11 Aug 2008 to 11 Jan 2009 in which to enter the National Phase has been filed . Address for service in Australia - Shelston IP 60 Margaret Street Sydney NSW 2000

30 April 2009 Section 223 Application Allowed

Not Given The time in which to enter the National Phase has been extended to 11 Jan 2009. Address for service in Australia - Shelston IP 60 Margaret Street Sydney NSW 2000

7 May 2009 PCT application entered the National Phase

PCT publication WO2007/081341 Priority application(s): WO2007/081341

25 June 2009 Alteration of Name

The name of the applicant has been altered to Teva Pharmaceutical Industries Ltd. 2007

4 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.